Home » Topics » BioWorld Science

BioWorld Science
RSS

VYN-201 reduces key inflammatory biomarkers involved in vitiligo pathogenesis in preclinical model

March 7, 2022

Modulation of RICTOR/mTORC2 axis is an approach for sensorineural hearing loss

March 7, 2022

Regulation of BIN1 ameliorates dynamin-related myopathy

March 7, 2022

Novel UV-mediated antigen-presenting nanoparticles for mRNA delivery to virus-specific T cells

March 7, 2022

PEAK3 promotes cell proliferation and migration in vitro

March 7, 2022

Novartis discloses EZH2 and EED inhibitors

March 7, 2022

Medshine Discovery identifies new BRD4 inhibitors

March 7, 2022

Chengdu Easton Pharmaceutical synthesizes new mu-opioid receptor agonists

March 7, 2022

Shenzhen Chipscreen Biosciences discloses new PTPN11 inhibitors

March 7, 2022

Chinese investigators patent PAK4 inhibitors

March 7, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...